RACHAEL KEMP: Open Payments
NPI 1053771170 · MT STERLING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 52 payments from 14 companies in 2025. Trend: 2023 $1,031 · 2024 $1,120 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $397 |
| Antares Pharma, Inc. | 6 | $117 |
| Lilly USA, LLC | 5 | $88 |
| Novo Nordisk Inc | 4 | $74 |
| ABBVIE INC. | 4 | $69 |
| Amgen Inc. | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Exact Sciences Corporation | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: FARXIGA, XYOSTED, JARDIANCE, VRAYLAR, OTEZLA, CAPLYTA, AIRSUPRA, REXULTI.
Industry payments across OH — which companies pay providers there.
